Page last updated: 2024-09-03

reboxetine and Long Sleeper Syndrome

reboxetine has been researched along with Long Sleeper Syndrome in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, A; Cooper-Kazaz, R; Lerer, B1
Corbo, M; Fiori, F; Martinotti, G; Sepede, G1
De Risio, S; Della Marca, G; Di Giannantonio, M; Farina, B; Mazza, S; Mennuni, G1
Leon, AC; Nelson, JC; Portera, L1

Reviews

1 review(s) available for reboxetine and Long Sleeper Syndrome

ArticleYear
Reboxetine in clinical practice: a review.
    La Clinica terapeutica, 2012, Volume: 163, Issue:4

    Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Depression; Humans; Morpholines; Reboxetine; Sleep Wake Disorders

2012

Trials

2 trial(s) available for reboxetine and Long Sleeper Syndrome

ArticleYear
The effects of reboxetine on human sleep architecture in depression: preliminary results.
    Journal of affective disorders, 2002, Volume: 71, Issue:1-3

    Topics: Adult; Antidepressive Agents; Depression; Electroencephalography; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Sleep Wake Disorders

2002
Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine.
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:11

    Topics: Adrenergic Uptake Inhibitors; Adult; Anxiety Disorders; Depression; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Libido; Male; Morpholines; Norepinephrine; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Sexual Dysfunctions, Psychological; Sleep Wake Disorders; Treatment Outcome

2005

Other Studies

1 other study(ies) available for reboxetine and Long Sleeper Syndrome

ArticleYear
Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine.
    Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:2

    Topics: Adult; Depressive Disorder, Major; Drug Synergism; Drug Therapy, Combination; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Reboxetine; Sleep Wake Disorders; Triiodothyronine; Young Adult

2010